Ironwood Pharmaceuticals IRWD Cash Flow Statement
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| $26.29M+2,888% | $880K+100% | -$1.03B-689% | $175.07M-66.9% | ||
| $1.88M-6.5% | $2.01M+27.7% | $1.58M+11.1% | $1.42M-6.9% | ||
| $17.25M-42.2% | $29.85M-6.7% | $32.01M+18.3% | $27.05M+21.4% | ||
| $42.55M-37.5% | $68.09M-6.3% | $72.64M+10.5% | $65.74M+120% | ||
| -$35.15M— | —— | —— | —— | ||
| $6.52M+132% | -$20.28M— | —— | —— | ||
| -$367K— | —— | -$4.22M-30.9% | -$3.22M-436% | ||
| $4.11M+140% | -$10.26M— | —— | $10.82M+884% | ||
| $1.69M+8.3% | $1.56M— | —— | —— | ||
| -$2.37M-9.0% | -$2.18M-9.1% | -$2M-2.5% | -$1.95M-6.1% | ||
| —— | $103.55M-43.5% | $183.43M-33.0% | $273.76M+4.5% | ||
| $35K-75.4% | $142K-48.0% | $273K+38.6% | $197K-39.7% | ||
| -$35K+75.4% | -$142K+100.0% | -$1.03B-520,874% | -$197K+39.7% | ||
| $216K-98.0% | $11.01M+73.2% | $6.36M-33.4% | $9.54M-51.3% | ||
| $216K+100% | -$106.97M— | —— | -$359.93M-7,811% | ||
| —— | —— | —— | —— | ||
| —— | —— | -$565.78M-1,668% | $36.07M-86.0% | ||
| $30.33M-6.8% | $32.56M+140% | $13.55M+136% | $5.75M-20.4% | ||
| $3.54M-57.9% | $8.41M-15.5% | $9.95M+115% | $4.62M+33.7% | ||
| $1.88M-6.5% | $2.01M+27.7% | $1.58M+11.1% | $1.42M-6.9% | ||
| -$4.11M— | —— | —— | -$11.53M— | ||
| -$2.37M-9.0% | -$2.18M-9.1% | -$2M-2.5% | -$1.95M-6.1% | ||
| $4.11M+140% | -$10.26M— | —— | $10.82M+884% | ||
| -$447K— | —— | —— | -$153K-368% | ||
| -$367K— | —— | -$4.22M-30.9% | -$3.22M-436% | ||
| $1.69M+8.3% | $1.56M— | —— | —— | ||
| $1.67M-12.4% | $1.9M— | —— | —— | ||
| $216K-98.0% | $11.01M+73.2% | $6.36M— | —— | ||
| $3.54M-57.9% | $8.41M-15.5% | $9.95M+115% | $4.62M+33.7% | ||
| —— | $103.41M-43.5% | $183.15M-33.1% | $273.63M+5.0% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Ironwood Pharmaceuticals generate?
- Ironwood Pharmaceuticals (IRWD) generated $147.2M in operating cash flow over the trailing twelve months.
- Where does Ironwood Pharmaceuticals's cash flow data come from?
- Every line is extracted from Ironwood Pharmaceuticals's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
